Spine and orthopedic companies made strides with new robots in 2024.
Citi opened a “90-day positive catalyst watch” on shares of Zimmer Biomet (ZBH) while keeping a Neutral rating on the name with a $120 price ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback